| 臺大學術典藏 |
2022-05-11T08:41:07Z |
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
|
Lip, Gregory Y H; Kotalczyk, Agnieszka; Teutsch, Christine; Diener, Hans-Christoph; Dubner, Sergio J; Halperin, Jonathan L; Ma, Chang-Sheng; Rothman, Kenneth J; Marler, Sabrina; Gurusamy, Venkatesh Kumar; FU-TIEN CHIANG; Huisman, Menno V |
| 國立成功大學 |
2024-09 |
Comparative effectiveness and tolerability of calcitonin gene-related peptide (CGRP) monoclonal antibodies and onabotulinumtoxinA in chronic migraine: A multicenter, real-world study in Taiwan
|
Wang;Yen-Feng;Yang;Fu-Chi;Chen;Lu-An;Chang;Ting-Yu;Su;Hui-Chen;Yang;Chun-Pai;Tu;Yi-Hsien;Tzeng;Yi-Shiang;Chen;Shih-Pin;Fuh;Jong-Ling;Lai;Kuan-Lin;Ling;Yu-Hsiang;Chen;Wei-Ta;Wang;Shuu-Jiun |
| 國立成功大學 |
2024-04 |
Comparative Effectiveness of Adjuvant Therapy on Survival in Patients With Metastatic Colorectal Cancer
|
Wu;Chih-chien;Su;Chien-chou;Chen;Yu-hsun;Hsu;Chao-wen;Chang;Yu-ching;Su;Yi-chia |
| 臺大學術典藏 |
2018-09-10T18:07:27Z |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Ho, C.-M. and Lee, C.-H. and Lee, M.-C. and Zhang, J.-F. and Wang, J.-Y. and Hu, R.-H. and Lee, P.-H.; REY-HENG HU; CHENG-MAW HO |
| 臺大學術典藏 |
2020-02-11T03:53:49Z |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Cheng-Maw Ho;Lee C.-H.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Hu R.-H.;Lee P.-H.; CHENG-MAW HO; Lee C.-H.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Hu R.-H.; Lee P.-H. |
| 臺大學術典藏 |
2020-02-24T01:33:43Z |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Ho C.-M.;Lee C.-H.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Rey-Heng Hu;Lee P.-H.; Ho C.-M.; Lee C.-H.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; REY-HENG HU; Lee P.-H. |
| 臺大學術典藏 |
2020-08-13T05:24:03Z |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Ho C.-M.; Lee C.-H.; Lee M.-C.; Zhang J.-F.; JANN-YUAN WANG; Hu R.-H.; Lee P.-H. |
| 臺大學術典藏 |
2018 |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
|
Ho C.-M.;Lee C.-H.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Hu R.-H.;Po-Huang Lee; Ho C.-M.; Lee C.-H.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Hu R.-H.; PO-HUANG LEE |
| 國家衛生研究院 |
2015-10 |
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in terms of major cardiovascular disease outcomes in elderly patients: A nationwide population-based cohort study
|
Chien, SC;Ou, SM;Shih, CJ;Chao, PW;Li, SY;Lee, YJ;Kuo, SC;Wang, SJ;Chen, TJ;Tarng, DC;Chu, H;Chen, YT |
| 國家衛生研究院 |
2016-05 |
Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy
|
Shih, CJ;Chen, HT;Kuo, SC;Li, SY;Lai, PH;Chen, SC;Ou, SM;Chen, YT |
